Global Autoimmune Hepatitis Treatment Market Size, Status and Forecast 2020-2026

August 2020 | 90 pages | ID: G36F5C597F81EN
QYResearch

Abstracts

This report focuses on the global Autoimmune Hepatitis Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Autoimmune Hepatitis Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Gilead Sciences, Inc.
• Acorda Therapeutics, Inc.
• Allergan & Novartis
• Intercept Pharmaceuticals, Inc.
• Hightidetx
• Shire Plc.
• NGM Biopharmaceuticals, Inc.
• EA Pharma
• BiomX
• CymaBay Therapeutics
• Conatus Pharmaceuticals, Inc.
• Durect Corporation
• Sirnaomics, Inc.
• Shenzhen HighTide Biopharmaceuticals Ltd.

Market segment by Type, the product can be split into

• Table Product
• Inject Product
• Others

Market segment by Application, split into

• Hospital
• Clinic
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Autoimmune Hepatitis Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Autoimmune Hepatitis Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Autoimmune Hepatitis Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Autoimmune Hepatitis Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Autoimmune Hepatitis Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Table Product
  1.4.3 Inject Product
  1.4.4 Others
1.5 Market by Application
  1.5.1 Global Autoimmune Hepatitis Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Clinic
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Autoimmune Hepatitis Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Autoimmune Hepatitis Treatment Industry
    1.6.1.1 Autoimmune Hepatitis Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Autoimmune Hepatitis Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Autoimmune Hepatitis Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Autoimmune Hepatitis Treatment Market Perspective (2015-2026)
2.2 Autoimmune Hepatitis Treatment Growth Trends by Regions
  2.2.1 Autoimmune Hepatitis Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Autoimmune Hepatitis Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Autoimmune Hepatitis Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Autoimmune Hepatitis Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Autoimmune Hepatitis Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Autoimmune Hepatitis Treatment Players by Market Size
  3.1.1 Global Top Autoimmune Hepatitis Treatment Players by Revenue (2015-2020)
  3.1.2 Global Autoimmune Hepatitis Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Autoimmune Hepatitis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Autoimmune Hepatitis Treatment Market Concentration Ratio
  3.2.1 Global Autoimmune Hepatitis Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Autoimmune Hepatitis Treatment Revenue in 2019
3.3 Autoimmune Hepatitis Treatment Key Players Head office and Area Served
3.4 Key Players Autoimmune Hepatitis Treatment Product Solution and Service
3.5 Date of Enter into Autoimmune Hepatitis Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Autoimmune Hepatitis Treatment Historic Market Size by Type (2015-2020)
4.2 Global Autoimmune Hepatitis Treatment Forecasted Market Size by Type (2021-2026)

5 AUTOIMMUNE HEPATITIS TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Autoimmune Hepatitis Treatment Market Size by Application (2015-2020)
5.2 Global Autoimmune Hepatitis Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Autoimmune Hepatitis Treatment Market Size (2015-2020)
6.2 Autoimmune Hepatitis Treatment Key Players in North America (2019-2020)
6.3 North America Autoimmune Hepatitis Treatment Market Size by Type (2015-2020)
6.4 North America Autoimmune Hepatitis Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Autoimmune Hepatitis Treatment Market Size (2015-2020)
7.2 Autoimmune Hepatitis Treatment Key Players in Europe (2019-2020)
7.3 Europe Autoimmune Hepatitis Treatment Market Size by Type (2015-2020)
7.4 Europe Autoimmune Hepatitis Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Autoimmune Hepatitis Treatment Market Size (2015-2020)
8.2 Autoimmune Hepatitis Treatment Key Players in China (2019-2020)
8.3 China Autoimmune Hepatitis Treatment Market Size by Type (2015-2020)
8.4 China Autoimmune Hepatitis Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Autoimmune Hepatitis Treatment Market Size (2015-2020)
9.2 Autoimmune Hepatitis Treatment Key Players in Japan (2019-2020)
9.3 Japan Autoimmune Hepatitis Treatment Market Size by Type (2015-2020)
9.4 Japan Autoimmune Hepatitis Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Autoimmune Hepatitis Treatment Market Size (2015-2020)
10.2 Autoimmune Hepatitis Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Autoimmune Hepatitis Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Autoimmune Hepatitis Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Autoimmune Hepatitis Treatment Market Size (2015-2020)
11.2 Autoimmune Hepatitis Treatment Key Players in India (2019-2020)
11.3 India Autoimmune Hepatitis Treatment Market Size by Type (2015-2020)
11.4 India Autoimmune Hepatitis Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Autoimmune Hepatitis Treatment Market Size (2015-2020)
12.2 Autoimmune Hepatitis Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Autoimmune Hepatitis Treatment Market Size by Type (2015-2020)
12.4 Central & South America Autoimmune Hepatitis Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Gilead Sciences, Inc.
  13.1.1 Gilead Sciences, Inc. Company Details
  13.1.2 Gilead Sciences, Inc. Business Overview and Its Total Revenue
  13.1.3 Gilead Sciences, Inc. Autoimmune Hepatitis Treatment Introduction
  13.1.4 Gilead Sciences, Inc. Revenue in Autoimmune Hepatitis Treatment Business (2015-2020))
  13.1.5 Gilead Sciences, Inc. Recent Development
13.2 Acorda Therapeutics, Inc.
  13.2.1 Acorda Therapeutics, Inc. Company Details
  13.2.2 Acorda Therapeutics, Inc. Business Overview and Its Total Revenue
  13.2.3 Acorda Therapeutics, Inc. Autoimmune Hepatitis Treatment Introduction
  13.2.4 Acorda Therapeutics, Inc. Revenue in Autoimmune Hepatitis Treatment Business (2015-2020)
  13.2.5 Acorda Therapeutics, Inc. Recent Development
13.3 Allergan & Novartis
  13.3.1 Allergan & Novartis Company Details
  13.3.2 Allergan & Novartis Business Overview and Its Total Revenue
  13.3.3 Allergan & Novartis Autoimmune Hepatitis Treatment Introduction
  13.3.4 Allergan & Novartis Revenue in Autoimmune Hepatitis Treatment Business (2015-2020)
  13.3.5 Allergan & Novartis Recent Development
13.4 Intercept Pharmaceuticals, Inc.
  13.4.1 Intercept Pharmaceuticals, Inc. Company Details
  13.4.2 Intercept Pharmaceuticals, Inc. Business Overview and Its Total Revenue
  13.4.3 Intercept Pharmaceuticals, Inc. Autoimmune Hepatitis Treatment Introduction
  13.4.4 Intercept Pharmaceuticals, Inc. Revenue in Autoimmune Hepatitis Treatment Business (2015-2020)
  13.4.5 Intercept Pharmaceuticals, Inc. Recent Development
13.5 Hightidetx
  13.5.1 Hightidetx Company Details
  13.5.2 Hightidetx Business Overview and Its Total Revenue
  13.5.3 Hightidetx Autoimmune Hepatitis Treatment Introduction
  13.5.4 Hightidetx Revenue in Autoimmune Hepatitis Treatment Business (2015-2020)
  13.5.5 Hightidetx Recent Development
13.6 Shire Plc.
  13.6.1 Shire Plc. Company Details
  13.6.2 Shire Plc. Business Overview and Its Total Revenue
  13.6.3 Shire Plc. Autoimmune Hepatitis Treatment Introduction
  13.6.4 Shire Plc. Revenue in Autoimmune Hepatitis Treatment Business (2015-2020)
  13.6.5 Shire Plc. Recent Development
13.7 NGM Biopharmaceuticals, Inc.
  13.7.1 NGM Biopharmaceuticals, Inc. Company Details
  13.7.2 NGM Biopharmaceuticals, Inc. Business Overview and Its Total Revenue
  13.7.3 NGM Biopharmaceuticals, Inc. Autoimmune Hepatitis Treatment Introduction
  13.7.4 NGM Biopharmaceuticals, Inc. Revenue in Autoimmune Hepatitis Treatment Business (2015-2020)
  13.7.5 NGM Biopharmaceuticals, Inc. Recent Development
13.8 EA Pharma
  13.8.1 EA Pharma Company Details
  13.8.2 EA Pharma Business Overview and Its Total Revenue
  13.8.3 EA Pharma Autoimmune Hepatitis Treatment Introduction
  13.8.4 EA Pharma Revenue in Autoimmune Hepatitis Treatment Business (2015-2020)
  13.8.5 EA Pharma Recent Development
13.9 BiomX
  13.9.1 BiomX Company Details
  13.9.2 BiomX Business Overview and Its Total Revenue
  13.9.3 BiomX Autoimmune Hepatitis Treatment Introduction
  13.9.4 BiomX Revenue in Autoimmune Hepatitis Treatment Business (2015-2020)
  13.9.5 BiomX Recent Development
13.10 CymaBay Therapeutics
  13.10.1 CymaBay Therapeutics Company Details
  13.10.2 CymaBay Therapeutics Business Overview and Its Total Revenue
  13.10.3 CymaBay Therapeutics Autoimmune Hepatitis Treatment Introduction
  13.10.4 CymaBay Therapeutics Revenue in Autoimmune Hepatitis Treatment Business (2015-2020)
  13.10.5 CymaBay Therapeutics Recent Development
13.11 Conatus Pharmaceuticals, Inc.
  10.11.1 Conatus Pharmaceuticals, Inc. Company Details
  10.11.2 Conatus Pharmaceuticals, Inc. Business Overview and Its Total Revenue
  10.11.3 Conatus Pharmaceuticals, Inc. Autoimmune Hepatitis Treatment Introduction
  10.11.4 Conatus Pharmaceuticals, Inc. Revenue in Autoimmune Hepatitis Treatment Business (2015-2020)
  10.11.5 Conatus Pharmaceuticals, Inc. Recent Development
13.12 Durect Corporation
  10.12.1 Durect Corporation Company Details
  10.12.2 Durect Corporation Business Overview and Its Total Revenue
  10.12.3 Durect Corporation Autoimmune Hepatitis Treatment Introduction
  10.12.4 Durect Corporation Revenue in Autoimmune Hepatitis Treatment Business (2015-2020)
  10.12.5 Durect Corporation Recent Development
13.13 Sirnaomics, Inc.
  10.13.1 Sirnaomics, Inc. Company Details
  10.13.2 Sirnaomics, Inc. Business Overview and Its Total Revenue
  10.13.3 Sirnaomics, Inc. Autoimmune Hepatitis Treatment Introduction
  10.13.4 Sirnaomics, Inc. Revenue in Autoimmune Hepatitis Treatment Business (2015-2020)
  10.13.5 Sirnaomics, Inc. Recent Development
13.14 Shenzhen HighTide Biopharmaceuticals Ltd.
  10.14.1 Shenzhen HighTide Biopharmaceuticals Ltd. Company Details
  10.14.2 Shenzhen HighTide Biopharmaceuticals Ltd. Business Overview and Its Total Revenue
  10.14.3 Shenzhen HighTide Biopharmaceuticals Ltd. Autoimmune Hepatitis Treatment Introduction
  10.14.4 Shenzhen HighTide Biopharmaceuticals Ltd. Revenue in Autoimmune Hepatitis Treatment Business (2015-2020)
  10.14.5 Shenzhen HighTide Biopharmaceuticals Ltd. Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Autoimmune Hepatitis Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Autoimmune Hepatitis Treatment Revenue
Table 3. Ranking of Global Top Autoimmune Hepatitis Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Autoimmune Hepatitis Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Table Product
Table 6. Key Players of Inject Product
Table 7. Key Players of Others
Table 8. COVID-19 Impact Global Market: (Four Autoimmune Hepatitis Treatment Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Autoimmune Hepatitis Treatment Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Autoimmune Hepatitis Treatment Players to Combat Covid-19 Impact
Table 13. Global Autoimmune Hepatitis Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Autoimmune Hepatitis Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Autoimmune Hepatitis Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Autoimmune Hepatitis Treatment Market Share by Regions (2015-2020)
Table 17. Global Autoimmune Hepatitis Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Autoimmune Hepatitis Treatment Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Autoimmune Hepatitis Treatment Market Growth Strategy
Table 23. Main Points Interviewed from Key Autoimmune Hepatitis Treatment Players
Table 24. Global Autoimmune Hepatitis Treatment Revenue by Players (2015-2020) (Million US$)
Table 25. Global Autoimmune Hepatitis Treatment Market Share by Players (2015-2020)
Table 26. Global Top Autoimmune Hepatitis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autoimmune Hepatitis Treatment as of 2019)
Table 27. Global Autoimmune Hepatitis Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Autoimmune Hepatitis Treatment Product Solution and Service
Table 30. Date of Enter into Autoimmune Hepatitis Treatment Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Autoimmune Hepatitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 33. Global Autoimmune Hepatitis Treatment Market Size Share by Type (2015-2020)
Table 34. Global Autoimmune Hepatitis Treatment Revenue Market Share by Type (2021-2026)
Table 35. Global Autoimmune Hepatitis Treatment Market Size Share by Application (2015-2020)
Table 36. Global Autoimmune Hepatitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. Global Autoimmune Hepatitis Treatment Market Size Share by Application (2021-2026)
Table 38. North America Key Players Autoimmune Hepatitis Treatment Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Autoimmune Hepatitis Treatment Market Share (2019-2020)
Table 40. North America Autoimmune Hepatitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. North America Autoimmune Hepatitis Treatment Market Share by Type (2015-2020)
Table 42. North America Autoimmune Hepatitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. North America Autoimmune Hepatitis Treatment Market Share by Application (2015-2020)
Table 44. Europe Key Players Autoimmune Hepatitis Treatment Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Autoimmune Hepatitis Treatment Market Share (2019-2020)
Table 46. Europe Autoimmune Hepatitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Autoimmune Hepatitis Treatment Market Share by Type (2015-2020)
Table 48. Europe Autoimmune Hepatitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Autoimmune Hepatitis Treatment Market Share by Application (2015-2020)
Table 50. China Key Players Autoimmune Hepatitis Treatment Revenue (2019-2020) (Million US$)
Table 51. China Key Players Autoimmune Hepatitis Treatment Market Share (2019-2020)
Table 52. China Autoimmune Hepatitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. China Autoimmune Hepatitis Treatment Market Share by Type (2015-2020)
Table 54. China Autoimmune Hepatitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. China Autoimmune Hepatitis Treatment Market Share by Application (2015-2020)
Table 56. Japan Key Players Autoimmune Hepatitis Treatment Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Autoimmune Hepatitis Treatment Market Share (2019-2020)
Table 58. Japan Autoimmune Hepatitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Autoimmune Hepatitis Treatment Market Share by Type (2015-2020)
Table 60. Japan Autoimmune Hepatitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Autoimmune Hepatitis Treatment Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Autoimmune Hepatitis Treatment Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Autoimmune Hepatitis Treatment Market Share (2019-2020)
Table 64. Southeast Asia Autoimmune Hepatitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Autoimmune Hepatitis Treatment Market Share by Type (2015-2020)
Table 66. Southeast Asia Autoimmune Hepatitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Autoimmune Hepatitis Treatment Market Share by Application (2015-2020)
Table 68. India Key Players Autoimmune Hepatitis Treatment Revenue (2019-2020) (Million US$)
Table 69. India Key Players Autoimmune Hepatitis Treatment Market Share (2019-2020)
Table 70. India Autoimmune Hepatitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. India Autoimmune Hepatitis Treatment Market Share by Type (2015-2020)
Table 72. India Autoimmune Hepatitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. India Autoimmune Hepatitis Treatment Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Autoimmune Hepatitis Treatment Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Autoimmune Hepatitis Treatment Market Share (2019-2020)
Table 76. Central & South America Autoimmune Hepatitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Autoimmune Hepatitis Treatment Market Share by Type (2015-2020)
Table 78. Central & South America Autoimmune Hepatitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Autoimmune Hepatitis Treatment Market Share by Application (2015-2020)
Table 80. Gilead Sciences, Inc. Company Details
Table 81. Gilead Sciences, Inc. Business Overview
Table 82. Gilead Sciences, Inc. Product
Table 83. Gilead Sciences, Inc. Revenue in Autoimmune Hepatitis Treatment Business (2015-2020) (Million US$)
Table 84. Gilead Sciences, Inc. Recent Development
Table 85. Acorda Therapeutics, Inc. Company Details
Table 86. Acorda Therapeutics, Inc. Business Overview
Table 87. Acorda Therapeutics, Inc. Product
Table 88. Acorda Therapeutics, Inc. Revenue in Autoimmune Hepatitis Treatment Business (2015-2020) (Million US$)
Table 89. Acorda Therapeutics, Inc. Recent Development
Table 90. Allergan & Novartis Company Details
Table 91. Allergan & Novartis Business Overview
Table 92. Allergan & Novartis Product
Table 93. Allergan & Novartis Revenue in Autoimmune Hepatitis Treatment Business (2015-2020) (Million US$)
Table 94. Allergan & Novartis Recent Development
Table 95. Intercept Pharmaceuticals, Inc. Company Details
Table 96. Intercept Pharmaceuticals, Inc. Business Overview
Table 97. Intercept Pharmaceuticals, Inc. Product
Table 98. Intercept Pharmaceuticals, Inc. Revenue in Autoimmune Hepatitis Treatment Business (2015-2020) (Million US$)
Table 99. Intercept Pharmaceuticals, Inc. Recent Development
Table 100. Hightidetx Company Details
Table 101. Hightidetx Business Overview
Table 102. Hightidetx Product
Table 103. Hightidetx Revenue in Autoimmune Hepatitis Treatment Business (2015-2020) (Million US$)
Table 104. Hightidetx Recent Development
Table 105. Shire Plc. Company Details
Table 106. Shire Plc. Business Overview
Table 107. Shire Plc. Product
Table 108. Shire Plc. Revenue in Autoimmune Hepatitis Treatment Business (2015-2020) (Million US$)
Table 109. Shire Plc. Recent Development
Table 110. NGM Biopharmaceuticals, Inc. Company Details
Table 111. NGM Biopharmaceuticals, Inc. Business Overview
Table 112. NGM Biopharmaceuticals, Inc. Product
Table 113. NGM Biopharmaceuticals, Inc. Revenue in Autoimmune Hepatitis Treatment Business (2015-2020) (Million US$)
Table 114. NGM Biopharmaceuticals, Inc. Recent Development
Table 115. EA Pharma Business Overview
Table 116. EA Pharma Product
Table 117. EA Pharma Company Details
Table 118. EA Pharma Revenue in Autoimmune Hepatitis Treatment Business (2015-2020) (Million US$)
Table 119. EA Pharma Recent Development
Table 120. BiomX Company Details
Table 121. BiomX Business Overview
Table 122. BiomX Product
Table 123. BiomX Revenue in Autoimmune Hepatitis Treatment Business (2015-2020) (Million US$)
Table 124. BiomX Recent Development
Table 125. CymaBay Therapeutics Company Details
Table 126. CymaBay Therapeutics Business Overview
Table 127. CymaBay Therapeutics Product
Table 128. CymaBay Therapeutics Revenue in Autoimmune Hepatitis Treatment Business (2015-2020) (Million US$)
Table 129. CymaBay Therapeutics Recent Development
Table 130. Conatus Pharmaceuticals, Inc. Company Details
Table 131. Conatus Pharmaceuticals, Inc. Business Overview
Table 132. Conatus Pharmaceuticals, Inc. Product
Table 133. Conatus Pharmaceuticals, Inc. Revenue in Autoimmune Hepatitis Treatment Business (2015-2020) (Million US$)
Table 134. Conatus Pharmaceuticals, Inc. Recent Development
Table 135. Durect Corporation Company Details
Table 136. Durect Corporation Business Overview
Table 137. Durect Corporation Product
Table 138. Durect Corporation Revenue in Autoimmune Hepatitis Treatment Business (2015-2020) (Million US$)
Table 139. Durect Corporation Recent Development
Table 140. Sirnaomics, Inc. Company Details
Table 141. Sirnaomics, Inc. Business Overview
Table 142. Sirnaomics, Inc. Product
Table 143. Sirnaomics, Inc. Revenue in Autoimmune Hepatitis Treatment Business (2015-2020) (Million US$)
Table 144. Sirnaomics, Inc. Recent Development
Table 145. Shenzhen HighTide Biopharmaceuticals Ltd. Company Details
Table 146. Shenzhen HighTide Biopharmaceuticals Ltd. Business Overview
Table 147. Shenzhen HighTide Biopharmaceuticals Ltd. Product
Table 148. Shenzhen HighTide Biopharmaceuticals Ltd. Revenue in Autoimmune Hepatitis Treatment Business (2015-2020) (Million US$)
Table 149. Shenzhen HighTide Biopharmaceuticals Ltd. Recent Development
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Autoimmune Hepatitis Treatment Market Share by Type: 2020 VS 2026
Figure 2. Table Product Features
Figure 3. Inject Product Features
Figure 4. Others Features
Figure 5. Global Autoimmune Hepatitis Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Others Case Studies
Figure 9. Autoimmune Hepatitis Treatment Report Years Considered
Figure 10. Global Autoimmune Hepatitis Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Autoimmune Hepatitis Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Autoimmune Hepatitis Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Autoimmune Hepatitis Treatment Market Share by Players in 2019
Figure 15. Global Top Autoimmune Hepatitis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autoimmune Hepatitis Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Autoimmune Hepatitis Treatment Revenue in 2019
Figure 17. North America Autoimmune Hepatitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Autoimmune Hepatitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Autoimmune Hepatitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Autoimmune Hepatitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Autoimmune Hepatitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Autoimmune Hepatitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Autoimmune Hepatitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Gilead Sciences, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Gilead Sciences, Inc. Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2015-2020)
Figure 26. Acorda Therapeutics, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Acorda Therapeutics, Inc. Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2015-2020)
Figure 28. Allergan & Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Allergan & Novartis Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2015-2020)
Figure 30. Intercept Pharmaceuticals, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Intercept Pharmaceuticals, Inc. Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2015-2020)
Figure 32. Hightidetx Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Hightidetx Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2015-2020)
Figure 34. Shire Plc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Shire Plc. Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2015-2020)
Figure 36. NGM Biopharmaceuticals, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. NGM Biopharmaceuticals, Inc. Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2015-2020)
Figure 38. EA Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. EA Pharma Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2015-2020)
Figure 40. BiomX Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. BiomX Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2015-2020)
Figure 42. CymaBay Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. CymaBay Therapeutics Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2015-2020)
Figure 44. Conatus Pharmaceuticals, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Conatus Pharmaceuticals, Inc. Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2015-2020)
Figure 46. Durect Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Durect Corporation Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2015-2020)
Figure 48. Sirnaomics, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Sirnaomics, Inc. Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2015-2020)
Figure 50. Shenzhen HighTide Biopharmaceuticals Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Shenzhen HighTide Biopharmaceuticals Ltd. Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2015-2020)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed